跳至主要内容
临床试验/JPRN-UMIN000009218
JPRN-UMIN000009218已完成4 期

A Phase IV Clinical Trial of EMPYNASE P Tablets 18000 in Patients with ankle swelling after lateral ankle sprain injuries. - A Phase IV Clinical Trial of EMPYNASE P Tablets 18000 in Patients with ankle swelling after lateral ankle sprain injuries.

Kaken Pharmaceutical Co., LTD0 个研究点目标入组 200 人开始时间: 2012年10月31日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • - Patient with a surgical operation of ankle sprains - Patient with history of ankle surgeries or with planned ankle surgeries at the sprain side. - Patient coexisting with arthritis/ Arthritis Charcot-type / diabetic foot/ varicose vein/ etc. - Patient coexisting with systemic or localised edema. - Patient with history of drug-indused hypersensitivity. - Patient coexisting with coagulopathy. - Patient coexisting with aspirin induced asthma or history of the same.

研究者

相似试验